San Diego-based ViaCyte said it is ready to move into human testing with a new product intended for patients with Type 1 diabetes who are at high risk for acute, life-threatening complications from severe episodes of low blood sugar (hypoglycemia).
ViaCyte... Read more »
Gener8tor, a Wisconsin-based group that runs training programs for early-stage companies and invests in them, is considering bringing those programs to Indianapolis.
The organization is still finalizing its decision about whether to expand into the Hoosier State. But if Gener8tor... Read more »
San Antonio—Taylor Rhodes, the former Rackspace CEO who resigned at the beginning of this month, is taking the helm of a Chicago-based company, SMS Assist, which has software that aims to help large business chains manage maintenance and property management... Read more »
The Trump administration’s plan for strengthening the nation’s cyber defenses is starting to come into focus.
Rob Joyce, a special assistant to the president and the White House’s cybersecurity coordinator, spoke in Boston Monday at an event promoting the launch of... Read more »
Celgene reported Monday that an experimental pill for the main type of multiple sclerosis met its main goals in a two-year study. By the end of the year, the Summit, NJ, drugmaker will ask the FDA to consider the drug, ozanimod,... Read more »
One of the Northwest’s most intriguing startups has a new wad of cash. Bellevue, WA-based Echodyne said it has raised $29 million in Series B funding led by New Enterprise Associates. The company’s previous investors also participated in the round; they... Read more »
We are getting down to the wire—just two and a half weeks until Xconomy’s most unique, up close and personal event of the year: our sixth annual Napa Summit: The Xconomy Retreat on Technology, Jobs, and Growth. We have only about... Read more »
When Donald Trump heralded Ford’s announcement earlier this year that it would invest $1.2 billion in its Michigan plants, it was seen by some as the fulfillment of campaign promises to “bring jobs back” and put America first.
Last week, the... Read more »
Amgen revealed late Sunday that safety problems have emerged in clinical testing of its closely watched osteoporosis drug, romosozumab (Evenity)—a development that will at minimum delay the drug’s path to approval, if not keep it off the market altogether.
The Thousand... Read more »
Austin—Family lore holds that HO Maycotte’s great-grandfather shot off the leg of Pancho Villa, a Mexican revolutionary.
Maycotte, a serial entrepreneur based in Austin, grew up in San Miguel de Allende, Mexico, in a military-turned-entrepreneurial family. His family established... Read more »
In rare instances, a baby’s esophagus develops improperly during pregnancy, leaving a gap in this tube connecting the throat to the stomach. Babies born with this condition can’t eat by mouth, and they require surgery to repair the defect.
Bloomington, IN-based... Read more »
Catch up on news from Wisconsin’s innovation community with these recent headlines:
—Gener8tor, which has run training programs for entrepreneurs in Wisconsin and Minnesota, graduated five startups from its core accelerator program. Descriptions of the companies, which had been working from... Read more »
Call it a “three-peat,” a losing streak, or what you will. Just don’t call it a surprise.
On Thursday, the Ewing Marion Kauffman Foundation released its latest ranking of startup activity by state. For the third consecutive year, Wisconsin finished in... Read more »